BUY Venus Pipes & Tubes Limited — Sachin Janardan Sarvade, IDBI Capital Markets and Securities
bySachin Janardan Sarvade, IDBI Capital Markets and SecuritiesHorizon: NA (inferred Swing (≤2wk))9 Nov 2026via NDTV Profit (Live)
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
MACD above its signal line — bullish momentum
Technicals · macd·14 Nov · today
Venus Pipes & Tubes reported Q2 FY27 revenue of INR 361.1 crore, a 23.9% YoY increase, and EBITDA of INR 51.7 crore, up 9.1% YoY. The company also secured a INR 29 crore order from a data center custo
BSE · Company Update·5 Nov · 1w ago
Venus Pipes & Tubes reported unaudited financial results for the quarter ended September 30, 2026, and declared an interim dividend of Rs 0.50 per equity share.
BSE · Result·5 Nov · 1w ago
Venus Pipes & Tubes reported unaudited financial results for the quarter ended September 30, 2026, and declared an interim dividend of Rs. 0.50 per equity share.
BSE · Board Meeting·5 Nov · 1w ago
Venus Pipes & Tubes has received a Rs. 29 crore order for pipe spooling solutions from a data center customer, part of a larger Rs. 185 crore letter of intent.
NSE · Press Release·30 Oct · 2w ago
Nothing found in this tip’s window yet.
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Venus Pipes & Tubes
- BUY — ICICI Securities30 Oct 2026 · ~1 year · target ₹2,340 · Active
- BUY — Nuvama Wealth1 Oct 2026 · ~1 year · target ₹3,000 · Active
- BUY — Sahi Research31 Aug 2026 · ~2 weeks · target ₹1,700 · SL hit
- BUY — ICICI Securities24 Aug 2026 · ~1 year · target ₹2,200 · Target hit
- BUY — IDBI Capital10 Aug 2026 · ~3 months · target ₹1,955 · Target hit
More from Sachin Janardan Sarvade, IDBI Capital Markets and Securities
- BUY Gland Pharma11 Nov 2026 · ~1 year · target ₹4,415 · Active
- BUY Sansera Engineering11 Nov 2026 · ~1 year · target ₹6,265 · Active
- BUY Alkem Laboratories9 Nov 2026 · ~2 weeks · target ₹5,730 · Active
- BUY Wockhardt9 Nov 2026 · ~2 weeks · target ₹2,480 · Active
- BUY ICICI Bank6 Nov 2026 · ~2 weeks · target ₹1,785 · Active

